BR0211991A - HormÈnio do crescimento humano modificado - Google Patents
HormÈnio do crescimento humano modificadoInfo
- Publication number
- BR0211991A BR0211991A BR0211991-9A BR0211991A BR0211991A BR 0211991 A BR0211991 A BR 0211991A BR 0211991 A BR0211991 A BR 0211991A BR 0211991 A BR0211991 A BR 0211991A
- Authority
- BR
- Brazil
- Prior art keywords
- growth hormone
- human growth
- modified human
- present
- immunogenic
- Prior art date
Links
- 102000002265 Human Growth Hormone Human genes 0.000 title abstract 4
- 108010000521 Human Growth Hormone Proteins 0.000 title abstract 4
- 239000000854 Human Growth Hormone Substances 0.000 title abstract 3
- 230000002163 immunogen Effects 0.000 abstract 2
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
"HORMÈNIO DO CRESCIMENTO HUMANO MODIFICADO". A presente invenção refere-se à modificação do hormónio do crescimento humano (hGB) para resultar em proteínas do hormónio do crescimento humano, que são substancialmente não imunogênicas ou menos imunogênicas do que qualquer contraparte não-modificada, quando usadas in vivo. A presente invenção refere-se ainda, a seq³ências epítome de célula-T derivadas de hGH, as quais são imunogênicas.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01121153 | 2001-09-04 | ||
| PCT/EP2002/009716 WO2003020761A1 (en) | 2001-09-04 | 2002-08-30 | Modified human growth hormone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0211991A true BR0211991A (pt) | 2004-09-28 |
Family
ID=8178533
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0211991-9A BR0211991A (pt) | 2001-09-04 | 2002-08-30 | HormÈnio do crescimento humano modificado |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20050020494A1 (pt) |
| EP (1) | EP1427756A1 (pt) |
| JP (1) | JP2005501546A (pt) |
| KR (1) | KR20040039323A (pt) |
| CN (1) | CN1551888A (pt) |
| BR (1) | BR0211991A (pt) |
| CA (1) | CA2459138A1 (pt) |
| HU (1) | HUP0402334A3 (pt) |
| MX (1) | MXPA04001976A (pt) |
| PL (1) | PL369066A1 (pt) |
| RU (1) | RU2004110238A (pt) |
| WO (1) | WO2003020761A1 (pt) |
| ZA (1) | ZA200402602B (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004022593A2 (en) * | 2002-09-09 | 2004-03-18 | Nautilus Biotech | Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| US8906676B2 (en) * | 2004-02-02 | 2014-12-09 | Ambrx, Inc. | Modified human four helical bundle polypeptides and their uses |
| EP1640382A1 (en) * | 2004-08-16 | 2006-03-29 | Université de Liège | Anti-angiogenic peptides |
| US7998930B2 (en) | 2004-11-04 | 2011-08-16 | Hanall Biopharma Co., Ltd. | Modified growth hormones |
| US20080260820A1 (en) * | 2007-04-19 | 2008-10-23 | Gilles Borrelly | Oral dosage formulations of protease-resistant polypeptides |
| AU2008279550B2 (en) * | 2007-06-21 | 2012-08-09 | Angelica Therapeutics, Inc. | Modified toxins |
| EP2268297A4 (en) * | 2008-02-29 | 2011-11-16 | Angelica Therapeutics Inc | MODIFIED TOXINS |
| JP2016519651A (ja) | 2013-03-15 | 2016-07-07 | アンジェリカ セラピューティックス，インク． | 改質された毒素 |
| US11396254B2 (en) | 2017-09-07 | 2022-07-26 | Custom Truck & Equipment LLC | Railcar-mover vehicle |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE170630T1 (de) * | 1990-12-05 | 1998-09-15 | Novo Nordisk As | Proteine mit geänderten epitopen und verfahren zur deren herstellung |
| US5686268A (en) * | 1992-06-19 | 1997-11-11 | Pfizer Inc. | Fused proteins |
| JP2002512624A (ja) * | 1997-05-21 | 2002-04-23 | バイオベーション リミテッド | 非免疫原性タンパク質の製造方法 |
| GB9712892D0 (en) * | 1997-06-20 | 1997-08-20 | Eclagen Ltd | Identification of mhc binding peptides |
| EP1051432B1 (en) * | 1998-12-08 | 2007-01-24 | Biovation Limited | Method for reducing immunogenicity of proteins |
-
2002
- 2002-08-30 HU HU0402334A patent/HUP0402334A3/hu unknown
- 2002-08-30 MX MXPA04001976A patent/MXPA04001976A/es not_active Application Discontinuation
- 2002-08-30 CA CA002459138A patent/CA2459138A1/en not_active Abandoned
- 2002-08-30 CN CNA028172779A patent/CN1551888A/zh active Pending
- 2002-08-30 JP JP2003525031A patent/JP2005501546A/ja not_active Withdrawn
- 2002-08-30 US US10/488,662 patent/US20050020494A1/en not_active Abandoned
- 2002-08-30 KR KR10-2004-7003170A patent/KR20040039323A/ko not_active Application Discontinuation
- 2002-08-30 EP EP02769987A patent/EP1427756A1/en not_active Withdrawn
- 2002-08-30 WO PCT/EP2002/009716 patent/WO2003020761A1/en not_active Application Discontinuation
- 2002-08-30 BR BR0211991-9A patent/BR0211991A/pt not_active Application Discontinuation
- 2002-08-30 RU RU2004110238/04A patent/RU2004110238A/ru not_active Application Discontinuation
- 2002-08-30 PL PL02369066A patent/PL369066A1/xx unknown
-
2004
- 2004-04-01 ZA ZA200402602A patent/ZA200402602B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1551888A (zh) | 2004-12-01 |
| HUP0402334A3 (en) | 2007-03-28 |
| EP1427756A1 (en) | 2004-06-16 |
| HUP0402334A2 (hu) | 2005-02-28 |
| JP2005501546A (ja) | 2005-01-20 |
| MXPA04001976A (es) | 2004-06-07 |
| PL369066A1 (en) | 2005-04-18 |
| ZA200402602B (en) | 2005-05-06 |
| CA2459138A1 (en) | 2003-03-13 |
| WO2003020761A1 (en) | 2003-03-13 |
| KR20040039323A (ko) | 2004-05-10 |
| US20050020494A1 (en) | 2005-01-27 |
| RU2004110238A (ru) | 2005-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0212035A (pt) | Fator ix modificado | |
| EP1373301A4 (en) | WEAKNESS OF IMMUNOGENICITY OF FUSION PROTEINS | |
| BR9910089A (pt) | Composições e antìgenos de neisseria meningitidis | |
| EP1196444B8 (en) | Exendin-4 conjugates and their medical use | |
| BR9906927A (pt) | Proteìnas de neisseria meningitidis | |
| BG102714A (en) | Pharmaceutical composition for immunomodulation based on peptides and adjuvants | |
| DK1185691T3 (da) | Genomiske neisseriasekvenser og fremgangmåder til anvendelse deraf | |
| BR0007840A (pt) | Proteìnas de fusão her-2/neu | |
| BR0308860A (pt) | Fator viii modificado | |
| ATE323766T1 (de) | Glykosylierte leptinzusammensetzungen und zugehörige verfahren | |
| CY1111431T1 (el) | Μεταλλαγμενες πρωτεϊνες πλακουντιου αυξητικου παραγοντα τυπου 1, μεθοδος παρασκευης και εφαρμογες αυτων | |
| BR0211991A (pt) | HormÈnio do crescimento humano modificado | |
| EP1050532A3 (en) | Preparation of s,s and r,s amino acid isosteres | |
| EP1548107A4 (en) | CHROMOPROTEIN AND FLUOROPROTEINS | |
| BR0208041A (pt) | Interferon beta modificado com imunogenicidade reduzida | |
| EP1071443A4 (en) | ISOLATED PEPTIDES CORRESPOND THE NY-ESO-1 AMINO ACID SEQUENCES AND BIND TO MHC CLASS I AND MHC CLASS II MOLECULES AND THEIR USE | |
| EP1700913A4 (en) | FLUORESCENT PROTEINS | |
| BR0207018A (pt) | Leptina modificada com imunogenicidade reduzida | |
| BR0207704A (pt) | Alfa interferon modificado com imunogenicidade reduzida | |
| HUP0400703A2 (hu) | Csökkentett immunogenitású módosított eritropoietin (EPO) | |
| NO993407L (no) | Fremstilling av proteinpreparater med nedsatt aggregatinnhold | |
| AU2001248822A1 (en) | Gd3-mimetic peptides | |
| BR0207905A (pt) | Protamina modificada com imunogenicidade reduzida | |
| AU3172095A (en) | Coccidiosis poultry vaccine | |
| EP2088197A3 (en) | Haemophilus influenzae antigens and corresponding DNA fragments |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |